Supreme Court Further Limits Liability of Generics for Faulty Drugs
Posted 07/3/13
By Gordon Schnell
In what is being hailed as a major victory for generic drug makers (but not necessarily for consumers), the Supreme Court ruled last week that these companies cannot be held liable for defects in the design of their products. The decision follows from the Court's 2011 ruling that similarly shielded the generics from liability for inadequate safety warnings on their drug labels. Taken together,...